Joseph Laning, PhD

Company: Astellas Pharma US

Job title: Executive Director, CMC Operations

Email: joseph.laning@astellas.com

Bio:

Dr. Laning is currently the Executive Director of CMC Operations at the Astellas Institute for Regenerative Medicine (AIRM).  He joined Astellas in 2018 as the Director of Cell Manufacturing and managed the growth of cell therapeutics manufacturing capabilities at AIRM. Dr. Laning has spent the past 26 years seeking to translate innovative concepts into products in the fields of regenerative medicine and stem cell therapies. Before joining Astellas he has held positions in preclinical, process development, analytical development, and manufacturing for product-driven biotechnology companies.  He served as Senior Director of the Massachusetts Stem Cell Bank and more recently as CTO at Provia Laboratories leading strategic implementation of their cGMP cell and tissue banking operations.  Current work centers on developing and enhancing PSC-derived cell therapy products for delivery of DS and DP for AIRM clinical programs as well as the scale up and automation for delivery of commercial scale cell therapeutics. He received his BA in Biology from Boston University and his PhD in Immunology from Harvard University. He is a member of the International Society for Cell and Gene Therapy (ISCT) and is the ISCT voting delegate to the United States Pharmacopeia (USP). He is also a member of the PhRMA Global Quality and Manufacturing Work Group, CMC Core Team.

Location: Southborough, Massachusetts, United States

LinkedIn: https://www.linkedin.com/in/jclaning112409/

For contact information, please email james.milburn@hansonwade.com